A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)
This study has been completed.
Study NCT00152958
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received on September 8, 2005.
Last Updated on May 18, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
